Stoke Therapeutics, Inc. - Common Stock (STOK)
CUSIP: 86150R107
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,529,259
- Total 13F shares
- 43,072,954
- Share change
- +1,760,174
- Total reported value
- $569,403,611
- Price per share
- $13.21
- Number of holders
- 88
- Value change
- +$19,595,358
- Number of buys
- 49
- Number of sells
- 32
Quarterly Holders Quick Answers
What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86150R107:
Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Skorpios Trust |
13F
|
Company |
25%
|
14,443,681
|
$304,039,000 | — | 31 Mar 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
6.3%
|
3,644,248
|
$76,711,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
4.8%
|
2,775,581
|
$58,426,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
4.4%
|
2,552,129
|
$53,722,000 | — | 31 Mar 2022 | |
| Redmile Group, LLC |
13F
|
Company |
3.5%
|
2,024,368
|
$42,613,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
1,939,390
|
$40,824,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.5%
|
1,422,352
|
$29,942,000 | — | 31 Mar 2022 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
2.5%
|
1,420,530
|
$29,902,000 | — | 31 Mar 2022 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
2.3%
|
1,336,500
|
$28,133,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.1%
|
1,188,115
|
$25,011,000 | — | 31 Mar 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.9%
|
1,087,807
|
$22,898,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
954,025
|
$20,082,000 | — | 31 Mar 2022 | |
| Octagon Capital Advisors LP |
13F
|
Company |
1.4%
|
813,456
|
$17,123,000 | — | 31 Mar 2022 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.98%
|
564,516
|
$11,883,000 | — | 31 Mar 2022 | |
| M28 Capital Management LP |
13F
|
Company |
0.92%
|
527,150
|
$11,097,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.76%
|
435,771
|
$9,172,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.74%
|
427,997
|
$9,009,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.74%
|
423,863
|
$8,922,000 | — | 31 Mar 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.47%
|
271,886
|
$5,723,000 | — | 31 Mar 2022 | |
| Artal Group S.A. |
13F
|
Company |
0.43%
|
250,000
|
$5,263,000 | — | 31 Mar 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
205,463
|
$4,325,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
186,635
|
$3,929,000 | — | 31 Mar 2022 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.32%
|
182,591
|
$3,844,000 | — | 31 Mar 2022 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.3%
|
175,000
|
$3,684,000 | — | 31 Mar 2022 | |
| Fort Point Capital Partners LLC |
13F
|
Company |
0.28%
|
160,000
|
$3,368,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.26%
|
151,660
|
$3,194,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.26%
|
150,732
|
$3,173,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
0.25%
|
145,600
|
$3,064,880 | — | 31 Mar 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.23%
|
131,674
|
$2,772,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.22%
|
128,532
|
$2,706,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
114,042
|
$2,400,000 | — | 31 Mar 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.12%
|
68,350
|
$1,439,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.1%
|
57,879
|
$1,392,000 | — | 31 Mar 2022 | |
| Amitell Capital Pte Ltd |
13F
|
Company |
0.11%
|
64,807
|
$1,364,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
62,698
|
$1,320,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.11%
|
62,065
|
$1,306,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.09%
|
51,941
|
$1,093,000 | — | 31 Mar 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.08%
|
44,844
|
$944,000 | — | 31 Mar 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.07%
|
40,495
|
$852,000 | — | 31 Mar 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.07%
|
40,000
|
$842,000 | — | 31 Mar 2022 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.07%
|
38,393
|
$808,000 | — | 31 Mar 2022 | |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY |
13F
|
Company |
0.06%
|
36,124
|
$760,000 | — | 31 Mar 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.06%
|
34,499
|
$755,349 | — | 31 Mar 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.06%
|
34,714
|
$731,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
30,500
|
$642,000 | — | 31 Mar 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.04%
|
25,030
|
$527,000 | — | 31 Mar 2022 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.04%
|
23,013
|
$484,000 | — | 31 Mar 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.04%
|
20,560
|
$433,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
19,800
|
$417,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
19,608
|
$412,000 | — | 31 Mar 2022 |
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q2 2022
As of 30 Jun 2022,
Stoke Therapeutics, Inc. - Common Stock (STOK) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,072,954 shares.
The largest 10 holders included
Skorpios Trust, RTW INVESTMENTS, LP, FMR LLC, MORGAN STANLEY, VANGUARD GROUP INC, Redmile Group, LLC, BlackRock Inc., COWEN AND COMPANY, LLC, WELLINGTON MANAGEMENT GROUP LLP, and Cormorant Asset Management, LP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
96
Q2 2022 holders
88
Holder diff
-8
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.